| SESSION NAME |
ASAM (Pharmacists, Pyschologists, Physicians, Physicians Assistants) |
ASWB (Social Worker) |
NEMSD (Nurses) |
NAADAC (Counselor) |
| SATURDAY | ASAM | ASWB | NEMSD | NAADAC |
| The Certified Medication Assistd Treatment Advocate (CMA) Training Course (Registration Required) | 0 | 8.0 | 8.0 | 8.0 |
| MAT Waiver Training | 8.5 | 8.5 | 8.5 | 8.5 |
| Romancing the Brain/Conflict Resolution in Recovery (CRR) | 0 | 7.5 | 7.5 | 7.5 |
| Confidentiality and MAT | 3.0 | 3.0 | 3.0 | 3.0 |
| Accreditation | 4.0 | 4.0 | 4.0 | 4.0 |
| Triple E for HCV Engagement Education and Eradication | 4.0 | 4.0 | 4.0 | 4.0 |
| SUNDAY | ASAM | ASWB | NEMSD | NAADAC |
| Opioid Maintenance Pharmacotherapy: A Course for Clinicians (Registration Required) | 8.0 | 8.0 | 8.0 | 8.0 |
| Long-acting Opioid Agonist Medications: Research and Clinical Practice | 4.0 | 4.0 | 4.0 | 4.0 |
| Transforming Care Delivery: High Reliability in Medication Assisted Treatment | 3.0 | 3.0 | 3.0 | 3.0 |
| Expanding Access to MAT in Correctional Settings | 3.0 | 3.0 | 3.0 | 3.0 |
| Presentations by the World Federation for the Treatment of Opioid Dependence | 4.0 | 4.0 | 4.0 | 4.0 |
| Florida Judges and Court Staff Session (Closed Session) | 4.0 | 4.0 | 4.0 | 4.0 |
| MONDAY | ASAM | ASWB | NEMSD | NAADAC |
| Poster Sessions | 1.25 | 1.25 | 1.25 | 1.25 |
| PL1: Opening Plenary Session: State of Affairs – The Opioid Epidemic | 1.5 | 1.5 | 1.5 | 1.5 |
| A1: Foundations of Medication Assisted Treatment | 1.5 | 1.5 | 1.5 | 1.5 |
| A2: The Criminal Justice System: An Effective Access Point to Treating Opioid Addiction | 1.5 | 1.5 | 1.5 | 1.5 |
| A3: Community Engagement Workshop for Opioid Treatment Programs | 1.5 | 1.5 | 1.5 | 1.5 |
| A4: Practical Methods to Increase Retention in Medication Assisted Treatment | 1.5 | 1.5 | 1.5 | 1.5 |
| A5: A Clinical Conundrum: Pain, Addiction or Both | 1.5 | 1.5 | 1.5 | 1.5 |
| #1: State Actions to Support Provider Innovation: Statutory, Regulatory and Administrative Reform | 1.5 | 1.5 | 1.5 | 1.5 |
| #2: When Disaster Strikes: Partnerships and Strategies for a Coordinated Response to Hurricane Florence | 1.5 | 1.5 | 1.5 | 1.5 |
| #3: Claims Trends and Risk Management in an Increasingly Litigious World | 1.5 | 1.5 | 1.5 | 1.5 |
| Hot Topic Roundtable: The Image of MAT and Related Stigma: Challenges and Opportunities | 0 | 1.5 | 1.5 | 1.5 |
| Hot Topic Roundtable: Using Technology to Improve Care | 1.5 | 1.5 | 1.5 | 1.5 |
| Hot Topic Roundtable: Medications for Opioid Use Disorders: Which One is Best? | 1.5 | 1.5 | 1.5 | 1.5 |
| Hot Topic Roundtable: Legal Cannabis in OTPs: Implications for Programs and Treatment Plans | 0 | 1.5 | 1.5 | 1.5 |
| Hot Topic Roundtable: Insurance Parity (MHPAEA) and Access: An Uncertain Present and Future | 0 | 1.5 | 1.5 | 1.5 |
| Poster Sessions | 1.0 | 1.0 | 1.0 | 1.0 |
| B1: Therapeutic Partnerships: The Most Important Evidence-Based Practice | 1.5 | 1.5 | 1.5 | 1.5 |
| B2: Connecting Community Outpatient Treatment Program to Corrections for Pregnant Patients | 1.5 | 1.5 | 1.5 | 1.5 |
| B3: Improving LGBT+ Care Through Inclusivity: A Community-Based Perspective | 1.5 | 1.5 | 1.5 | 1.5 |
| B4: Community Technical Assistance in Response to the Opioid Epidemic | 1.5 | 1.5 | 1.5 | 1.5 |
| B5: Recovery Coaching in OTPs: Making a Difference | 1.5 | 1.5 | 1.5 | 1.5 |
| TUESDAY | ASAM | ASWB | NEMSD | NAADAC |
| PL2: Middle Plenary Session: A Continuum of Care: The Criminal Justice Role in Treatment | 1.5 | 1.5 | 1.5 | 1.5 |
| C1: Assessment and Treatment for Patients with Co-Occurring Disorders | 1.5 | 1.5 | 1.5 | 1.5 |
| C2: Implementing Medication Assisted Treatment in the Justice System | 1.5 | 1.5 | 1.5 | 1.5 |
| C3: MAT in the Middle of Nowhere: Clever Solutions to a Rural Health Crisis | 1.5 | 1.5 | 1.5 | 1.5 |
| C4: Enhancing Patient Care by Avoiding Burnout and Compassion Fatigue | 1.5 | 1.5 | 1.5 | 1.5 |
| C5: Tackling Stigma Associated with SUDs | 1.5 | 1.5 | 1.5 | 1.5 |
| D1: Group Therapy for Substance Use Disorders: Basics and Beyond | 1.5 | 1.5 | 1.5 | 1.5 |
| D2: Anywhere, Anytime: A Model for Universal Access to Opioid Medication | 1.5 | 1.5 | 1.5 | 1.5 |
| D3: Racial and Ethnic Disparities in OUD: Implications for Cultural-Competence | 1.5 | 1.5 | 1.5 | 1.5 |
| D4: Managing Co-occurring Opioid Use Disorder and Chronic Pain | 1.5 | 1.5 | 1.5 | 1.5 |
| D5: Implementing Telehealth in MAT to Better Serve Rural Areas | 1.5 | 1.5 | 1.5 | 1.5 |
| The Role of Craving and Dual Disorders in Organizing Services for Heroin Addicts | 1.5 | 1.5 | 1.5 | 1.5 |
| WEDNESDAY | ASAM | ASWB | NEMSD | NAADAC |
| E1: Strengthening Trauma Informed Practices Within OTPs | 1.5 | 1.5 | 1.5 | 1.5 |
| E2: Implementing and Sustaining Enhanced MAT in Corrections: Considerations for Diversion, Recidivism and Saving Lives | 1.5 | 1.5 | 1.5 | 1.5 |
| E3: Therapeutic use of Cannabis: Facts, Myths, & Policy Considerations | 1.5 | 1.5 | 1.5 | 1.5 |
| E4: Peer Services for Medication Assisted Treatment (The MARS Project) | 1.5 | 1.5 | 1.5 | 1.5 |
| E5: Resistance or Resilience: Mind and Body Responses | 1.5 | 1.5 | 1.5 | 1.5 |
| F1:Shattering the Stigma and Shedding the Shame | 1.5 | 1.5 | 1.5 | 1.5 |
| F2: Naloxone Distribution in the Opioid Treatment Program Setting | 1.5 | 1.5 | 1.5 | 1.5 |
| F3: Breaking All Barriers: Increasing Access to Care through the Country’s First 24/7 OTP | 1.5 | 1.5 | 1.5 | 1.5 |
| F4: Unleash The Power of Parents & Peers: Engaging & Empowering Families | 1.5 | 1.5 | 1.5 | 1.5 |
| F5: Using Technology to Empower Families and Concerned Others to Support Loved Ones with Opioid Use Disorder | 1.5 | 1.5 | 1.5 | 1.5 |
| PL3: Closing Plenary Session: Combating the Opioid Epidemic as a Nation and around the World | 1.5 | 1.5 | 1.5 | 1.5 |
This is the final notification for our early registration conference deadline of today, Monday, June 30, 2025. The registration must be submitted prior to midnight. We hope to see you in Philadelphia this October!
Register ➡️ aatodconference.com
#aatod2025
#theevolvingfieldofopioidtreatment
4 days ago
It's Here! #aatod2025 Conference Workshop Lineup
View the comprehensive workshop listing and descriptions of the conference sessions 👉 bit.ly/4jHyzXC
The conference will continue to be the world’s premier training and education event for the treatment of opioid use disorders. We trust you will find the conference an enriching and energizing experience. We hope to see you in Philadelphia!
#theevolvingfieldoftreatment
3 weeks ago
#ICYMI
Visit Exhibits & Sponsorship Opportunities for the upcoming #aatod2025 Conference.
👇
bit.ly/3FAAnUc
REMINDER- Exhibit booths will be assigned based on priority points until May 31, 2025. After the initial round of booth assignments, booths will be assigned on a first-come, first-served basis.
#theevolvingfieldoftreatment
1 month ago
Don’t miss out on the chance to show your support, share your products/services and secure your sponsorship at the AATOD 2025 Conference, The world’s premier training conference event for the Treatment of Opioid Use Disorder. #aatod2025
A full list of sponsorship items and exhibit details can also be found in the Exhibitor Brochure ➡️ bit.ly/4kmbXN8.
1 month ago
AATOD Statement - The Role of The Drug Enforcement Administration in Approving the Use of Methadone Products in Treating Opioid Use Disorder ➡️ bit.ly/4kmbXN8
1 month ago
On behalf of the AATOD Conference Management Team, we are excited to share that the online Exhibitor and Sponsor Portal for the 2025 AATOD Conference, taking place October 4–8, 2025, in Philadelphia, is now open.
You can now purchase exhibit booths, select sponsorship opportunities, and register badges directly through the portal. You can also learn more about exhibitor opportunities and benefits on our website.
bit.ly/44rrRB6
#aatod2025
#theevolvingfieldoftreatment
2 months ago
Statement for the Record
We are sharing AATOD's latest statement that corrects misleading testimony before the Senate Select Committee on Aging.
Get the details ➡️bit.ly/3DmpAvT⬅️
4 months ago
⏰THE CLOCK IS TICKING!
Please submit your proposals by tonight’s deadline - 3/4/25 at 11:59 PM EST.
SUBMIT ➡️ www.aatodconference.com
#aatod2025
#theevolvingfieldofopioidtreatment
4 months ago
⏰ TIME IS TICKING
The Call for Presentations Submission deadline is TOMORROW, March 4th.
Submit Presentation ➡️ aatodconference.com
This conference video message places a spotlight on AATOD's 2025 Workshop Committee Co-Chairs, Robert C. Lambert, MA, LADC & Allegra Schorr, MS. View their message and gain insight on what can be expected from the robust workshop lineup that is underway ➡️
https://bit.ly/3XpYwTa.
4 months ago
NEW Call for Presentations Submission Deadline: Tues, March 4, 2025
This week's video message places a spotlight on AATOD's 2025 Conference Chair, Joshua Nirella, MSOL. Click below to view as he formally invites each of you to attend this year's conference event, and calls for your personal involvement by submitting an abstract for a workshop or poster presentation.
https://youtu.be/EkSxR5j5GxI?si=ZSZvvzYHq1rVMBi3
#aatod2025
#theevolvingfieldofopioidtreatment
4 months ago
This is the final notification for our early reg conference deadline of today, 6/30. The registration must be submitted prior to midnight. We hope to see you in Philadelphia this October!
http://aatodconference.com
#aatod2025
#theevolvingfieldofopioidtreatment
The Evolving Field of Opioid Treatment
AATOD proudly presents the world’s premier training conference event for the treatment of Opioid Use Disorder.
Early Registration Deadline: June 30, 2025
www.aatodconference.com
It’s Here…Conference Workshop Lineup!
View the comprehensive workshop listing and descriptions of the conference sessions.
Marketing & Advertising Opportunities
Exhibits & Sponsorship
Don’t miss out on the chance to show your support, share your products/services and secure your sponsorship at the AATOD 2025 Conference. You can now purchase exhibit booths, select sponsorship opportunities and register badges directly through the portal HERE. You can also learn more about exhibit opportunities and benefits on our conference website.
#aatod2025 Conference Countdown
